Amesite Inc. stock & equity tools

Dr. Ann Marie Sastry founded Amesite in 2017 in Detroit, Michigan, after previously co-founding Sakti3, a solid-state battery company acquired by Dyson for $90 million in 2015. Amesite's current flagship product is NurseMagic, an AI-driven documentation platform for post-acute care settings (home health, hospice, skilled nursing, and home care) that reduces nursing charting time from roughly 20 minutes to 20 seconds per note. The company listed on Nasdaq in 2020 and reported $108,050 in Q2 2026 revenue, a 69% quarter-over-quarter increase, with approximately 12 employees. In May 2026, Amesite won its largest enterprise deployment, covering a 2,700-patient-census home care organization.

Sources: sec.gov · ir.amesite.com

Equity comp at Amesite Inc.

• Amesite operates three distinct equity instruments simultaneously: (1) stock options for employees with a vesting period that changed from 2 years in FY2023/FY2024 to 4 years in FY2025, all with 10-year terms; (2) annual RSU grants to directors (worth $100,000 per year) that vest on the one-year anniversary of grant; and (3) a Deferred Fee Plan for Directors under which outside directors may take their quarterly cash retainer as deferred stock units (DSUs, shares issued in lieu of cash that are held and delivered at a future date) instead, with settlement deferred until the director leaves the board or a change in control occurs. The 2018 Equity Incentive Plan provides no automatic acceleration upon a change in control at the plan level; acceleration requires explicit language in individual award agreements.
• Vesting schedule: Employee stock options shifted from 2-year vesting (no cliff documented) in FY2023/FY2024 to 4-year vesting in FY2025. Director RSUs vest on the one-year anniversary of grant..

Sources: sec.gov · sec.gov · sec.gov

Researched 2026-05-28.